Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
215 studies found for:    Open Studies | "Psoriasis"
Show Display Options
Rank Status Study
1 Recruiting The Effect of Riboflavin on Moderate to Severe Plaque Type Psoriasis
Condition: Psoriasis
Interventions: Drug: Riboflavin;   Other: Placebo
2 Recruiting Efficacy and Safety Study of NP000888 in Subjects With Plaque and Nail Psoriasis
Condition: Psoriasis
Interventions: Drug: NP000888;   Drug: Vehicle
3 Recruiting Videocapillaroscopy Assessment During Systemic Agent Therapy in Psoriasis
Condition: Psoriasis
4 Recruiting Assessing the Long Term Effectiveness and Safety of Biotherapies in the Treatment of Cutaneous Psoriasis
Condition: Psoriasis
5 Not yet recruiting Assessing the Efficacy and Safety of Metformin in Treatment of Moderate Psoriasis
Condition: Psoriasis
Interventions: Drug: Metformin;   Drug: Placebo;   Drug: Topical Coal tar;   Drug: Topical calcipotriol
6 Recruiting Safety and Efficacy of Secukinumab in Mild Psoriasis
Condition: Psoriasis
Interventions: Drug: Secukinumab;   Drug: Placebo followed by Secukinumab
7 Recruiting Cutaneous Microcirculation and Nervous Sensitivity in Psoriasis
Condition: Psoriasis
Interventions: Other: Acetylcholine iontophoresis;   Other: Sodium Nitroprussiate iontophoresis;   Other: ppi water iontophoresis;   Other: Laser Doppler recording
8 Recruiting Pharmacogenomics Study on Treatment of Psoriasis Vulgaris by Methotrexate
Condition: Psoriasis Vulgaris
Intervention: Drug: Methotrexate
9 Recruiting A Study of GSK2981278 Ointment in Subjects With Plaque Psoriasis
Condition: Psoriasis
Interventions: Drug: GSK2981278 ointment;   Drug: Vehicle ointment
10 Recruiting Real-World Outcome of Psoriasis Subjects in Korea on Adalimumab
Condition: Psoriasis
11 Recruiting Psychotherapy for Patients With Psoriasis: Effects in Quality of Life
Condition: Psoriasis
Intervention: Behavioral: Psychotherapy
12 Recruiting Safety, Tolerability, PD & PK of Calcipotriene 0.005% Foam, Under Maximal Use in 12-16 Year Olds With Plaque Psoriasis
Condition: Psoriasis
Intervention: Drug: Calcipotriene 0.005% Foam
13 Recruiting Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy®) in the Treatment of Scalp Psoriasis
Condition: Scalp Psoriasis
Interventions: Drug: 0.25% Desoximetasone cream (Topoxy®);   Drug: 0.25% Desoximetasone cream (Topicorte®);   Drug: Placebo
14 Recruiting Study of Efficacy and Safety of Secukinumab in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis
Condition: Plaque Psoriasis
Interventions: Drug: Secukinumab 150 mg s.c.;   Drug: Secukinumab 300 mg s.c.;   Drug: Placebo
15 Recruiting International Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of BCD-085 in Various Doses in Patients With Moderate to Severe Plaque Psoriasis
Condition: Psoriasis
Interventions: Drug: BCD-085;   Other: Placebo
16 Recruiting Safety and Efficacy Study of Etanercept (Qiangke®) to Treat Moderate to Severe Plaque Psoriasis
Conditions: Plaque Psoriasis;   Psoriasis
Interventions: Biological: etanercept;   Biological: etanercept (half dose);   Drug: placebo
17 Recruiting An Efficacy, Safety, and Pharmacokinetics Study of Subcutaneously Administered Ustekinumab in the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Pediatric Participants Greater Than 6 to Less Than 12 Years of Age
Condition: Psoriasis
Interventions: Drug: Ustekinumab 0.75 mg/kg;   Drug: Ustekinumab 45 mg;   Drug: Ustekinumab 90 mg
18 Recruiting Study To Evaluate Safety And Efficacy Of PF-06700841 In Subjects With Moderate To Severe Plaque Psoriasis
Condition: Chronic Plaque Psoriasis
Interventions: Drug: PF-06700841;   Other: Placebo
19 Recruiting Study of the Efficacy of Early Intervention With Secukinumab 300 mg s.c. Compared to Narrow-band UVB in Patients With New-onset Moderate to Severe Plaque Psoriasis
Condition: Plaque Psoriasis
Interventions: Biological: Secukinumab;   Radiation: nbUVB;   Drug: Calcipotriol;   Drug: Betamethasone
20 Recruiting Icotinib Hydrochloride Cream in Patients With Mild to Moderate Psoriasis
Condition: Psoriasis
Interventions: Drug: 0.5% Icotinib hydrochloride cream;   Drug: 1.0% Icotinib hydrochloride cream;   Drug: 2.0% Icotinib hydrochloride cream;   Drug: 4.0% Icotinib hydrochloride cream;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.